Dr. Tyrone Malloy is an accomplished physician, researcher, and educator with more than 30 years of professional experience. In addition to being the principle researcher and chief executive officer of the Soapstone Center for Clinical Research, Dr. Tyrone Malloy contributes his time and expertise to many other projects and organizations, including Natera in San Carlos, California. Dedicated to elevating the science of prenatal testing, Natera is a genetic testing company that has developed technology capable of obtaining a range of genetic information from a small quantity of fetal DNA. Recently. Natera announced the release of Panorama, a new noninvasive prenatal test that is able to detect common chromosomal abnormalities, such as those causing Down syndrome, Patau syndrome, Edwards syndrome, and Turner syndrome. Using a simple blood draw from the mother, the Panorama test carries little to no risk, provides very accurate results, and can be performed during the first trimester of pregnancy. Just one example of the way Natera is advancing the science of safe prenatal testing. Panorama offers parents an accurate testing method that threatens neither the health of the mother nor that of the unborn baby